We are monitoring the impact of COVID-19 & Recession alarm on North America Pancreatic Cancer Market Get in touch with us for detailed analysis Know More
Share on

North America Pancreatic Cancer Market Research Report – Segmented By Treatment Type, Cancer Type, End Users & Region - Industry Analysis, Size, Share, Growth, Trends & Forecast (2022 to 2027)

Published: January, 2022
ID: 1204
Pages: 179

North America Pancreatic Cancer Market Size (2022 to 2027)

The size of the Pancreatic Cancer Market in North America is estimated to grow USD 1.42 billion by 2027 from USD 0.99 billion in 2022, growing at a CAGR of 7.54% during the forecast period.

The market for pancreatic cancer in North America is growing owing to the growing incidence of pancreatic cancer, growing population, and Increasing healthcare expenditure. The Significant rise in the number of people and growing concern about pancreatic cancer across the region propels the market growth. Pancreatic cancer is the 12th most frequent cancer among males and the 11th most common cancer among women globally. The most important factors that increase the risk are tobacco addiction and medical history. Also, Technological advancements in drug development about pancreatic cancer and evolving healthcare infrastructure are boosting the market growth during the forecast period. Growth in the pancreatic cancer therapy market will be driven by the introduction of drugs with novel mechanisms of action across several therapies, which are poised to meet high unmet needs in the US and 5EU. Moreover, the large number of unmet needs related to the disease attracting many multinational companies to invest in this division which is expected to expand the market growth. 

In late-stage pancreatic cancer patients, premium-priced treatments have been introduced in the previous three to four years. The market growth trend in the recent past indicates a shift in market consumption from chemotherapy to targeted treatments, as well as a shift in the treatment paradigm towards personalized medicine methods. Therefore, over the projection period, kinase inhibitors, which comprise many types of pipeline medicines presently under development, are likely to be the pioneers among pipeline agents.

However, high costs associated with the treatment, Inadequate results after treatment, and adverse side-effects are some of the factors restricting the market growth. The other factors, such as Difficulty in diagnosis during the early stages, Low success rates in clinical trials for cancer drugs, and limited treatment options, especially when the disease has spread to other organs or parts of the body, are the growth restraints of the market.

This research report on the North American Pancreatic Cancer Market has been segmented & sub-segmented into the following categories:

By Treatment Type:

  • Surgery
  • Chemotherapy
  • Radiation Therapy
  • Other

By Cancer Type:

  • Exocrine Pancreas Cancer
  • Endocrine Pancreas Cancer

By End User:

  • Hospitals
  • Clinics
  • Research Institutes
  • Others

By Country:

  • United States
  • Canada
  • Rest of North America

Geographically, the North American Pancreatic Cancer Market is projected to account for a rapid share during the forecast period. The market growth in the region is attributed to the increase in the incidence of patients with pancreas cancer, increasing healthcare expenditures, and the rising number of therapies launched in the market. In addition, the major companies in the region are conducting research and development activities, and increasing investment for the development of cancer therapeutics centers are most likely to augment the market growth.

Pancreatic cancer is the fourth-largest cause of cancer-related fatalities in the United States, after lung cancer and breast cancer, and the seventh most significant cause of cancer-related global deaths, with 432,242 deaths reported in 2018. The most prevalent type of pancreatic cancer is pancreatic adenocarcinoma (PDAC), which is categorized as an exocrine pancreatic cancer and accounts for 80% of all pancreatic cancer diagnoses. 

The US, however, is still expected to be the market leader in 2029, is valued twice as much as in 2019, thus highlighting interesting market dynamics for this indication based on incidence rates, clinical approaches, and product commercialization.

The Canadian pancreatic cancer market is projected to witness a promising share and contribute to the regional market. 

KEY MARKET PLAYERS:

Companies leading the North American pancreatic cancer market profiled in this report are Eli Lilly, Amgen, Inc., Celgene Corp., F. Hoffmann-La Roche, Clovis Oncology Inc., Pfizer, Novartis AG, Threshold Pharmaceuticals Inc., Aduro BioTech Inc., Infinity Pharmaceuticals Inc., and NewLink Genetics Corp. 

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 Type of Treatment                  

                                5.1.1 Introduction           

                                5.1.2 Surgery    

                                5.1.3 Chemotherapy     

                                5.1.4 Radiation Therapy

                                5.1.5 Others      

                                5.1.6 Y-o-Y Growth Analysis, By Type of Treatment          

                                5.1.7 Market Attractiveness Analysis, By Type of Treatment         

                                5.1.8 Market Share Analysis, By Type of Treatment          

                5.2 Type                              

                                5.2.1 Introduction           

                                5.2.2 Exocrine Pancreas Cancer

                                5.2.3 Endocrine Pancreas Cancer              

                                5.2.4 Y-o-Y Growth Analysis, By Type      

                                5.2.5 Market Attractiveness Analysis, By Type     

                                5.2.6 Market Share Analysis, By Type      

                5.3 End-users                   

                                5.3.1 Introduction           

                                5.3.2 Hospitals  

                                5.3.3 Clinics        

                                5.3.4 Research Institutes             

                                5.3.5 Others      

                                5.3.6 Y-o-Y Growth Analysis, By End-users            

                                5.3.7 Market Attractiveness Analysis, By End-users          

                                5.3.8 Market Share Analysis, By End-users           

6. Geographical Analysis                                              

                6.1 Introduction                              

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Type of Treatment

                                                6.1.3.3 By Type

                                                6.1.3.4 By End-users

                                6.1.4 Market Attractiveness Analysis      

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Type of Treatment

                                                6.1.4.3 By Type

                                                6.1.4.4 By End-users

                                6.1.5 Market Share Analysis        

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Type of Treatment

                                                6.1.5.3 By Type

                                                6.1.5.4 By End-users

                6.2 United States                            

                6.3 Canada                         

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Eli Lilly                           

                                8.1.1 Overview

                                8.1.2 Type of Product    

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Amgen, Inc.                

                8.3 Celgene Corp.                           

                8.4 F. Hoffmann-La Roche                           

                8.5 Clovis Oncology Inc.                

                8.6 Pfizer                            

                8.7 Novartis AG                

                8.8 Threshold Pharmaceuticals Inc.                          

                8.9 Aduro BioTech Inc.                  

                8.10 Infinity Pharmaceuticals Inc.                             

                8.11 NewLink Genetics Corp.                      

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  1. North America Surgery Market, By Region, From 2022 - 2027 (USD Billion)
  2. North America Chemotherapy Market, By Region, From 2022 - 2027 (USD Billion)
  3. North America Radiation Therapy Market, By Region, From 2022 - 2027 (USD Billion)
  4. North America Others Market, By Region, From 2022 - 2027 (USD Billion)
  5. North America Pancreatic Cancer Market, By Type, From 2022 - 2027 (USD Billion)
  6. North America Exocrine Pancreas Cancer Market, By Region, From 2022 - 2027 (USD Billion)
  7. North America Endocrine Pancreas Cancer Market, By Region, From 2022 - 2027 (USD Billion)
  8. North America Pancreatic Cancer Market, By End-users, From 2022 - 2027 (USD Billion)
  9. North America Hospitals Market, By Region, From 2022 - 2027 (USD Billion)
  10. North America Clinics Market, By Region, From 2022 - 2027 (USD Billion)
  11. North America Research Institutes Market, By Region, From 2022 - 2027 (USD Billion)
  12. North America Others Market, By Region, From 2022 - 2027 (USD Billion)
  13. United States Pancreatic Cancer Market, By Type of Treatment, From 2022 - 2027 (USD Billion)
  14. United States Pancreatic Cancer Market, By Type, From 2022 - 2027 (USD Billion)
  15. United States Pancreatic Cancer Market, By End-users, From 2022 - 2027 (USD Billion)
  16. Canada Pancreatic Cancer Market, By Type of Treatment, From 2022 - 2027 (USD Billion)
  17. Canada Pancreatic Cancer Market, By Type, From 2022 - 2027 (USD Billion)
  18. Canada Pancreatic Cancer Market, By End-users, From 2022 - 2027 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample